US Patent Issued to Celgene on Nov. 18 for "Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same" (New Jersey Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,176, issued on Nov. 18, was assigned to Celgene Corp. (Summit, N.J.).

"Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same" was invented by Anjali Agrawal (Basking Ridge, N.J.), Biplob K. Mitra (Basking Ridge, N.J.), Prajwal Gunwanth Thool (Short Hills, N.J.), Shannon Higgins-Gruber (Scotch Plains, N.J.), Jennifer Almodovar Rodriguez (Cranford, N.J.) and Demin Liu (Berkeley Heights, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical compositions (e.g., oral dosage formulations) co...